NXTC Q2 2020 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena

NXTCNextCure, Inc.

$35M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$16M

Net Income

-$15M

EPS (Diluted)

$-6.33

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$333M

Total Liabilities

$12M

Stockholders' Equity

$322M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$1M	-100.0%
Gross Profit	$0	-$6M	+100.0%
Operating Income	-$16M	-$9M	-76.4%
Net Income	-$15M	-$8M	-76.5%